Inspiring Better Healthcare
Healthcare at Ipsos
What's New?
![]() | POINT OF VIEW When China sets the pace: How Europe can still shape the future of oncology innovation Exploring how China’s oncology pipeline is setting a faster pace for global development, and what it means for European biopharma. |
![]() | POINT OF VIEW From signal to specialist: Where IgAN treatment is losing pace New Ipsos research explores how delayed nephrology referral may limit opportunities for better long-term outcomes in IgAN. |
![]() | POINT OF VIEW Finding their position: Where GLP-1s fit in cardiorenal care Outside of metabolic disease treatment, we explore optimal treatment strategies for GLP-1s in heart failure and chronic kidney disease. |
![]() | POINT OF VIEW Why oncologists are prescribing GLP-1s Evidence-based understanding of why cancer specialists are embracing – and sometimes avoiding – GLP-1s. |
![]() | PRESS RELEASE Two-Thirds of People Living with Obesity Blame Themselves, Despite WHO Classifying Obesity as a Disease Ipsos releases key findings from the syndicated Global Perceptions of Obesity Study, which surveyed 14,500 people in 14 countries, to mark World Obesity Day 2026. |
![]() | WEBINAR Advances in Metabolic Therapeutics for Obesity, Diabetes and MASH Watch our cardiometabolic experts guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next |
![]() | RESEARCH SOLUTION Ipsos Rx Insight Store On-demand reports now available across multiple therapy areas and healthcare topics, ensuring access to the most relevant market insights for brand success. |






